ID   MERTK_RAT               Reviewed;         994 AA.
AC   P57097;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2000, sequence version 1.
DT   02-OCT-2024, entry version 170.
DE   RecName: Full=Tyrosine-protein kinase Mer;
DE            EC=2.7.10.1;
DE   AltName: Full=Proto-oncogene c-Mer;
DE   AltName: Full=Receptor tyrosine kinase MerTK;
DE   Flags: Precursor;
GN   Name=Mertk; Synonyms=Mer;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=RCS;
RX   PubMed=10699188; DOI=10.1093/hmg/9.4.645;
RA   D'Cruz P.M., Yasumura D., Weir J., Matthes M.T., Abderrahim H.,
RA   LaVail M.M., Vollrath D.;
RT   "Mutation of the receptor tyrosine kinase gene Mertk in the retinal
RT   dystrophic RCS rat.";
RL   Hum. Mol. Genet. 9:645-651(2000).
CC   -!- FUNCTION: Receptor tyrosine kinase that transduces signals from the
CC       extracellular matrix into the cytoplasm by binding to several ligands
CC       including LGALS3, TUB, TULP1 or GAS6. Regulates many physiological
CC       processes including cell survival, migration, differentiation, and
CC       phagocytosis of apoptotic cells (efferocytosis). Ligand binding at the
CC       cell surface induces autophosphorylation of MERTK on its intracellular
CC       domain that provides docking sites for downstream signaling molecules.
CC       Following activation by ligand, interacts with GRB2 or PLCG2 and
CC       induces phosphorylation of MAPK1, MAPK2, FAK/PTK2 or RAC1. MERTK
CC       signaling plays a role in various processes such as macrophage
CC       clearance of apoptotic cells, platelet aggregation, cytoskeleton
CC       reorganization and engulfment. Functions in the retinal pigment
CC       epithelium (RPE) as a regulator of rod outer segments fragments
CC       phagocytosis. Also plays an important role in inhibition of Toll-like
CC       receptors (TLRs)-mediated innate immune response by activating STAT1,
CC       which selectively induces production of suppressors of cytokine
CC       signaling SOCS1 and SOCS3 (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.1;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10028};
CC   -!- SUBUNIT: Interacts (upon activation) with TNK2; stimulates TNK2
CC       autophosphorylation. Interacts (via N-terminus) with extracellular
CC       ligands LGALS3, TUB, TULP1 and GAS6. Interacts with VAV1 in a
CC       phosphotyrosine-independent manner. Interacts with TIMD4; this
CC       interaction enhances TIMD4-mediated efferocytosis (By similarity).
CC       {ECO:0000250|UniProtKB:Q12866}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q12866};
CC       Single-pass type I membrane protein {ECO:0000250}.
CC   -!- PTM: Autophosphorylated on Tyr-744, Tyr-748 and Tyr-749 in the
CC       activation loop allowing full activity. Autophosphorylated on Tyr-867
CC       leading to recruitment of downstream partners of the signaling cascade
CC       such as PLCG2 (By similarity). {ECO:0000250}.
CC   -!- DISEASE: Note=Defects in Mertk are the cause of retinal dystrophy (rdy)
CC       in the royal college of surgeons (RCS) rats.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. AXL/UFO subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF208235; AAF44060.1; -; mRNA.
DR   PIR; PT0194; PT0194.
DR   RefSeq; NP_075232.1; NM_022943.1.
DR   AlphaFoldDB; P57097; -.
DR   SMR; P57097; -.
DR   BioGRID; 249230; 1.
DR   STRING; 10116.ENSRNOP00000023419; -.
DR   GlyCosmos; P57097; 14 sites, No reported glycans.
DR   GlyGen; P57097; 14 sites.
DR   iPTMnet; P57097; -.
DR   PhosphoSitePlus; P57097; -.
DR   PaxDb; 10116-ENSRNOP00000023419; -.
DR   Ensembl; ENSRNOT00000097978.1; ENSRNOP00000076826.1; ENSRNOG00000017319.5.
DR   Ensembl; ENSRNOT00055009610; ENSRNOP00055007421; ENSRNOG00055005926.
DR   Ensembl; ENSRNOT00060027596; ENSRNOP00060022174; ENSRNOG00060016090.
DR   Ensembl; ENSRNOT00065023398; ENSRNOP00065018208; ENSRNOG00065014153.
DR   GeneID; 65037; -.
DR   KEGG; rno:65037; -.
DR   UCSC; RGD:69283; rat.
DR   AGR; RGD:69283; -.
DR   CTD; 10461; -.
DR   RGD; 69283; Mertk.
DR   eggNOG; ENOG502QQQ3; Eukaryota.
DR   GeneTree; ENSGT00940000155669; -.
DR   HOGENOM; CLU_015796_0_0_1; -.
DR   InParanoid; P57097; -.
DR   OMA; QETRFGN; -.
DR   OrthoDB; 1614410at2759; -.
DR   PhylomeDB; P57097; -.
DR   TreeFam; TF317402; -.
DR   BRENDA; 2.7.10.1; 5301.
DR   Reactome; R-RNO-202733; Cell surface interactions at the vascular wall.
DR   PRO; PR:P57097; -.
DR   Proteomes; UP000002494; Chromosome 3.
DR   Bgee; ENSRNOG00000017319; Expressed in kidney and 20 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005615; C:extracellular space; ISO:RGD.
DR   GO; GO:0001750; C:photoreceptor outer segment; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0043235; C:receptor complex; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IBA:GO_Central.
DR   GO; GO:0043277; P:apoptotic cell clearance; ISO:RGD.
DR   GO; GO:0016477; P:cell migration; IBA:GO_Central.
DR   GO; GO:0051649; P:establishment of localization in cell; ISO:RGD.
DR   GO; GO:0046649; P:lymphocyte activation; ISO:RGD.
DR   GO; GO:0001779; P:natural killer cell differentiation; ISO:RGD.
DR   GO; GO:0001818; P:negative regulation of cytokine production; ISO:RGD.
DR   GO; GO:2000107; P:negative regulation of leukocyte apoptotic process; ISO:RGD.
DR   GO; GO:0051250; P:negative regulation of lymphocyte activation; ISO:RGD.
DR   GO; GO:0007399; P:nervous system development; IBA:GO_Central.
DR   GO; GO:0097350; P:neutrophil clearance; ISO:RGD.
DR   GO; GO:0006909; P:phagocytosis; IDA:RGD.
DR   GO; GO:0030168; P:platelet activation; ISO:RGD.
DR   GO; GO:0050766; P:positive regulation of phagocytosis; IDA:RGD.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:0060041; P:retina development in camera-type eye; ISO:RGD.
DR   GO; GO:0032940; P:secretion by cell; ISO:RGD.
DR   GO; GO:0007283; P:spermatogenesis; ISO:RGD.
DR   GO; GO:0034446; P:substrate adhesion-dependent cell spreading; ISO:RGD.
DR   GO; GO:0060068; P:vagina development; ISO:RGD.
DR   CDD; cd00063; FN3; 2.
DR   CDD; cd05749; IgI_2_Axl_Tyro3_like; 1.
DR   CDD; cd14204; PTKc_Mer; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 4.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR013151; Immunoglobulin_dom.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR050122; RTK.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   PANTHER; PTHR24416:SF257; TYROSINE-PROTEIN KINASE MER; 1.
DR   PANTHER; PTHR24416; TYROSINE-PROTEIN KINASE RECEPTOR; 1.
DR   Pfam; PF00041; fn3; 1.
DR   Pfam; PF00047; ig; 1.
DR   Pfam; PF13927; Ig_3; 1.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00060; FN3; 2.
DR   SMART; SM00409; IG; 2.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF49265; Fibronectin type III; 1.
DR   SUPFAM; SSF48726; Immunoglobulin; 2.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS50853; FN3; 2.
DR   PROSITE; PS50835; IG_LIKE; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding; Cell membrane; Disulfide bond; Glycoprotein;
KW   Immunoglobulin domain; Kinase; Membrane; Nucleotide-binding;
KW   Phosphoprotein; Proto-oncogene; Receptor; Reference proteome; Repeat;
KW   Signal; Transferase; Transmembrane; Transmembrane helix;
KW   Tyrosine-protein kinase.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000255"
FT   CHAIN           19..994
FT                   /note="Tyrosine-protein kinase Mer"
FT                   /id="PRO_0000024445"
FT   TOPO_DOM        19..497
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        498..518
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        519..994
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          86..181
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          192..268
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          281..376
FT                   /note="Fibronectin type-III 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          381..478
FT                   /note="Fibronectin type-III 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          582..852
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          24..77
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        55..77
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        718
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10028"
FT   BINDING         588..596
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         610
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         538
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q12866"
FT   MOD_RES         744
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q12866"
FT   MOD_RES         748
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q12866"
FT   MOD_RES         749
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q12866"
FT   MOD_RES         867
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q60805"
FT   CARBOHYD        108
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        165
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        202
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        210
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        229
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        289
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        311
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        324
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        331
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        349
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        384
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        390
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        437
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        449
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        109..170
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        213..257
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
SQ   SEQUENCE   994 AA;  109423 MW;  339717117FB4242B CRC64;
     MVLAPLLLGL LLLSALWNGG TAEKEEEIKP DQPFSGPLPG SLPADHRPFF APHSSGDQLS
     PSQTGRSHPA HTATPQMTSA ASNLLPPVAF KNTIGRIVLS EHKSVKFNCS INIPNVYQET
     AGISWWKDGK ELLGAHHSIT QFYPDEEGVS IIALFSITSV QRSDNGSYIC KMKVNDREVV
     SDPIYVEVQG LPYFTKQPES VNVTRNTAFN LTCQAVGPPE PVNIFWVQNS SRVNENPERS
     PSVLTVAGLT ETAVFSCEAH NDKGLTVSKG VQINIKVIPS PPTEVHILNS TAHSILVSWV
     PGFDGYSPLQ NCSIQVKEAD QLSNGSVMVF NTSASPHLYE VQQLQALANY SVTVSCRNEI
     GWSAVSPWIL ASTTEGAPAV APLNITVFLN ESSNNLEIRW TKPPIKRQDG ELVGYRISHV
     WESAGTSKEL SEEVSQNGSW AQVPVQMHNA TCTVRIAVIT KGGIGPFSEP VDVAIPEHSR
     VDYAPSSTPA PGNTESMLII LGCFCGFVLM GLILYLSLAI KRRVQETKFG GAFSEEDSQL
     VVNYRAKKSF CRRAIELTLQ SLGVSEELQN KLEDVVVDRN LLILGKVLGE GEFGSVMEGN
     LKQEDGTSQK VAVKTMKLDN FSLREIEEFL SEAACMKDFN HPNVIRLLGV CIELSSQGIP
     KPMVILPFMK YGDLHTFLLY SRIESVPKSI PLQTLLKFMV DIAQGMEYLS SRNFLHRDLA
     ARNCMLRDDM TVCVADFGLS KKIYSGDYYR QGRIAKMPVK WIAIESLADR VYTSKSDVWA
     FGVTMWEIAT RGMTPYPGVQ NHEMYDYLLH GHRLKQPEDC LDDLYEIMYS CWSADPLDRP
     TFSVLRLQLE KLSESLPDAQ DKESIIYINT QLLESCEGLA NRSSLAGLDM NIDPDSIIAS
     CTAGAAVSVV MAEVHENNLH EERYILNGGN EEWEDVASTP FATVTAGKDG VLPEDRLTKN
     GISWSHHSTL PLGSPSPDEL LFADDSSGDS EVLM
//
